Noura S Abul-Husn, MD, PhD

img_Noura S Abul-Husn
ASSOCIATE CLINICAL PROFESSOR | Medicine, Medical Genomics
Research Topics
Clinical Genomics, Genetics, Genomics
Multi-Disciplinary Training Area
Artificial Intelligence and Emerging Technologies in Medicine [AIET], Genetics and Genomic Sciences [GGS]

MD, Icahn School of Medicine at Mount Sinai

PhD, Icahn School of Medicine at Mount Sinai

Publications

Selected Publications

Association of high and moderate penetrance monogenic variants, polygenic risk, and family history with breast cancer in an ancestrally diverse population. Emily R. Soper, Nicole A. Casasanta, Bethany Dubois, Gillian M. Belbin, Eimear E. Kenny, Noura S. Abul-Husn. Cancer genetics

Genetic predictors of GLP1 receptor agonist weight loss and side effects. Qiaojuan Jane Su, James R. Ashenhurst, Wanwan Xu, Vinh Tran, R. Ryanne Wu, Catherine H. Weldon, Jingchunzi Shi, Barry Hicks, Joyce Y. Tung, Teague Sterling, Suyash Shringarpure, Anjali J. Shastri, Shubham Saini, Carrie Northover, Alex Moran, Matthew H. McIntyre, Keng Han Lin, Yanyu Liang, Alan Kwong, Matthew J. Kmiecik, Aly Khan, Reza Jabal, David A. Hinds, Larry Hengl, Julie M. Granka, Chris German, Shirin Fuller, Sarah L. Elson, Chris Eijsbouts, Emily DelloRusso, Payambr Dibaeinia, Devika Dhamija, Kahsaia de Brito, Sayantan Das, Zayn Cochinwala, Katelyn Kukar Bond, Robert K. Bell, Noura S. Abul-Husn, Stella Aslibekyan, Michael V. Holmes, Bertram L. Koelsch, Adam Auton. Nature

Genomic analyses implicate hormonal and metabolic dysregulation in polycystic ovary syndrome. Loes M.E. Moolhuijsen, Jia Zhu, Benjamin H. Mullin, Natàlia Pujol-Gualdo, Ky’Era V. Actkins, Jasmine A. Mack, Hridya Rao, Bhavi Trivedi, Katherine A. Kentistou, Yajie Zhao, David Westergaard, Jaakko S. Tyrmi, Gudmar Thorleifsson, Yanfei Zhang, Laura Wittemans, Amber DeVries, Kelly Brewer, Ryan Sisk, Rebecca Danning, Michael H. Preuss, Michelle R. Jones, Katherine S. Ruth, Marianne Andersen, Ricardo Azziz, Karina Banasik, Michael Boehnke, Linda Broer, Søren Brunak, Yee Ming Chan, Daniel I. Chasman, Mark Daly, David A. Ehrmann, Bart C. Fauser, Lars G. Fritsche, M. Geoffrey Hayes, Chunyan He, Hongyan Huang, Irina Kowalska, Peter Kraft, Richard S. Legro, Nan Lin, Ruth J. Loos, Yvonne V. Louwers, Reedik Magi, Mark I. McCarthy, Laure Morin-Papunen, Jean V. Morrison, Girish N. Nadkarni, Noura S. Abul-Husn, Andrea Dunaif. Nature Genetics

View All Publications

Population Genomic Health: Bridging Genomics into Clinical Care

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Abul-Husn during 2025 and/or 2026. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Inflection Medicine

Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)

  • Inflection Medicine

Outside Employment

  • 23andMe Research Institute

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.